Patompong UngprasertNarat SrivaliWonngarm KittanamongkolchaiMayo ClinicMahidol University2018-12-112019-03-142018-12-112019-03-142016-09-01Indian Journal of Dermatology, Venereology and Leprology. Vol.82, No.5 (2016), 489-49709733922037863232-s2.0-84983661488https://repository.li.mahidol.ac.th/handle/20.500.14594/41194© 2016 Indian Journal of Dermatology, Venereology, and Leprology Published by Wolters Kluwer - Medknow. Background and Objectives: Patients with psoriasis might have a higher risk of developing atrial fibrillation as a result of chronic inflammation. This study aimed to investigate this association by comprehensively reviewing all available evidence. Methods: We conducted a systematic review and meta-analysis of cohort studies that reported relative risk, hazard ratio, incidence ratio or standardized incidence ratio with 95% confidence intervals comparing the risk of incident atrial fibrillation in patients with psoriasis versus participants without psoriasis. Both retrospective and prospective cohort studies were eligible. Pooled risk ratio and 95% confidence intervals were calculated using random-effect, generic inverse variance methods of DerSimonian and Laird. Results: Three retrospective studies with 110,568 cases of psoriasis and 5,352,817 participants without psoriasis were included in this meta-analysis. The pooled risk ratio of subsequent development of atrial fibrillation in patients with psoriasis versus participants without psoriasis was 1.21 (95% confidence interval, 1.14-1.29). The statistical heterogeneity was low with an I2of 29%. Limitations: Coding-based design of the primary studies that had limited accuracy. Conclusions: Our meta-analysis demonstrated a statistically significant increase in the risk of incident atrial fibrillation among patients with psoriasis.Mahidol UniversityMedicineReviewSCOPUS10.4103/0378-6323.186480